These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6355946)

  • 1. [Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity].
    Hiddemann W; Büchner T; Andreeff M; Arlin Z; Wörmann B; Clarkson BD
    Onkologie; 1983 Aug; 6(4):179-83. PubMed ID: 6355946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
    Roberts MM; Juttner CA; To LB; Kimber RJ
    Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
    N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).
    Weinstein H; Ravindranath Y; Krischer J; Steuber P; Civin C; Gresik M; Vietti T
    Leukemia; 1992; 6 Suppl 2():52-4. PubMed ID: 1578941
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral induction and consolidation of acute myeloid leukemia with etoposide, 6-thioguanine, and idarubicin (ETI) in elderly patients: a randomized comparison with 5-day TAD. Finnish Leukemia Group.
    Ruutu T; Almqvist A; Hallman H; Honkanen T; Järvenpää E; Järventie G; Koistinen P; Koivunen E; Lahtinen R; Lehtinen M
    Leukemia; 1994 Jan; 8(1):11-5. PubMed ID: 8289475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive short-term chemotherapy for patients with acute myelogenous leukemia: long-term follow-up.
    Oblon DJ; Weiner RS; Kramer BS; Ross W; Noyes WD; Boyett J; Kitchens CS
    Cancer Treat Rep; 1985 Dec; 69(12):1425-7. PubMed ID: 2416439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homoharringtonine combined with cytarabine to treat chronic myelogenous leukemia in myeloid blast crisis and its impact on bone marrow CD34+CD7+ cells.
    Li Y; Deng Z; Zho J; Ding B; Shi Y; Li Y
    Acta Haematol; 2014; 132(2):172-6. PubMed ID: 24603361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
    Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
    Büchner T; Hiddemann W; Löffler G; Gassmann W; Maschmeyer G; Heit W; Hossfeld D; Weh H; Ludwig WD; Thiel E
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):76-9. PubMed ID: 1780757
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
    Demirer T; Petersen FB; Bensinger WI; Appelbaum FR; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner CD
    Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).
    Wörmann B; Hiddemann W; Frisch J; Zühlsdorf M; Rottmann R; Boeckmann A; Reuter C; Freire EA; Innig G; Schulz G
    Behring Inst Mitt; 1991 Dec; (90):28-38. PubMed ID: 1801688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia.
    Winton EF; Miller D; Vogler WR
    Cancer Treat Rep; 1981; 65(5-6):389-92. PubMed ID: 6165470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].
    Lemez P; Gáliková J; Haas T
    Vnitr Lek; 1999 Jun; 45(6):342-6. PubMed ID: 11045169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAB--a promising new treatment to improve remission rates in AML in the elderly?
    Wheatley K
    Br J Haematol; 2002 Aug; 118(2):432-3. PubMed ID: 12139727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
    Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
    Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
    Roberts MM; Dyson PG; Willson K; Juttner CA; To LB
    Bone Marrow Transplant; 1996 Jul; 18(1):41-5. PubMed ID: 8831994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside.
    Caballero MD; González M; Cañizo MC; Orfao A; Nieto MJ; San Miguel JF
    Leukemia; 1992 Aug; 6(8):856-8. PubMed ID: 1640739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Leukemia; 1994 Apr; 8(4):535-41. PubMed ID: 8152248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.